BJUI Mini Reviews - The Medical Management of Metastatic Renal Cell Carcinoma: Integrating New Guidelines and Recommendations
This review examines a landscape, radically changed by the introduction of five agents tested in phase III clinical trials, that have been designed to target tumour-related angiogenesis and signal transduction in renal cell carcinoma.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
